Default company panoramic image
E03fbf4f b275 4185 80bc dc05d7e6d6bc

Atturos

Atturos uses proteomics technology to help clinicians and patients make more informed treatment decisions for prostate cancer.

  • Stage Concept Only
  • Industry Biotechnology
  • Location Pilates Dublin . ie, Dublin, Ireland
  • Currency EUR
  • Founded January 2013
  • Employees 2
  • Website atturos.com

Company Summary

Atturos builds innovative biomarker-based diagnostic tests to support clinical decision making in prostate cancer. With its advanced protein biomarker discovery capability and MRM-based validation platform, Atturos has identified a panel of proteins predictive of extracapsular extension (ECE) in prostate cancer, which it is developing into a clinically validated test to ensure clinicians and patients make a more informed decision about treatment.

Team

  • Default avatar
    Stephen Pennington - CSO
    Prof

    Founder

  • Default avatar
    Dolores Cahill - CEO
    Prof

    Co-Founder